After you get a diagnosis of liposarcoma, a type of cancer that starts in fat cells, your doctor will discuss your treatment options with you. The main choices are surgery, radiation, and sometimes ...
Liposarcoma is cancer that starts in the fat cells. It is a type of soft tissue sarcoma. A liposarcoma can grow anywhere but most often develops in the abdomen or limbs. Liposarcoma is among the most ...
The Oral and Maxillofacial Pathology Registry of the Armed Forces Institute of Pathology in Washington, D.C. from 1970 to 2000 was reviewed for cases coded as “liposarcoma” and “lipoma.” Inclusion ...
Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST) SEAL was a phase II-III, multicenter, ...
Q: Which doctor should I consult if I have a lump with increasing size and pain? A: If someone is having lump of increasing size and pain,one should first visit a general practitioner who will refer ...
Liposarcoma is a type of cancer that starts in fatty tissue. It can develop anywhere on the body that has fat cells, but it typically appears in the abdomen or upper legs. In this article, we’ll look ...
A new or growing lump under your skin can be a symptom of liposarcoma, a type of cancer that starts in fat cells. Although the lump may be nothing serious, it's a good idea to get it checked out by ...
Liposarcomas are a rare type of malignancy with a very heterogeneous morphological appearance and clinical course. The therapeutic approach is based on histopathological classification and is ...
A healthy, 53-year-old man presented with a small, soft, nontender mass of his right upper arm that progressively grew larger and more firm during the 6 weeks before evaluation (Figure 1). The ...
De-intensification of preoperative radiation therapy is both effective and oncologically safe in patients with myxoid liposarcoma, an extremely rare type of soft tissue sarcoma (STS). The lower doses ...
Almost half of patients with advanced solid tumors or lymphomas experienced disease control with a drug that reactivates the TP53 tumor suppressor, a first-in-human study showed. Overall, the oral ...